Conversely, population studies have found no association between increased risk of diabetic retinopathy and GLP-1 RA use [104, 105], with a low odds ratio observed for exenatide (OR 0.16), liraglutide (OR 0.18), albiglutide (OR 0.09), and dulaglutide (OR 0.11) [106]
IGF-1 Long R3 is a modified version of insulin-like growth factor 1, a peptide engineered to remain active in your body for 20-30 hours instead of the mere minutes that natural IGF-1 survives
It has a fundamentally different chemical structure and mechanism of action from anabolic steroids and does not appear to interact with androgen or estrogen receptors in research models
It shows promise by linking weight loss to better sleep
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia
2022 Sep 19;24(6-8):98102